Anavex Life Sciences Corp (AVXL)

[falconer66a]

But Still A Distant, Blurred Image

Anavex is now in the center of everyone's radar screen.

Perhaps. But, in truth, there is no wide, public understanding or recognition of what Anavex Life Sciences has to offer. On the screen, it’s hazily clouded by all the other biotechs and big pharmas.

Think not? Ask anyone who should know about the company. Ask your physician. Or any stock advisor. “Anavex? Never heard of them. What do they sell?”

In time, Anavex will be widely known; when piles of positive clinical results come up from Australia or over from Spain; when those results start appearing in general news articles and broadcasts. News of that sort in the Wall Street Journal or Investor’s Business Daily won’t be seen or appreciated by the general public. But articles in the New York Times, in the manner of, “Australians Get Alzheimer’s Relief With New Drug” will put Anavex into public discussion.

“Hey, how come we don’t have that drug here?”